Atopic Eczema - From Epidemiology to Therapeutic Approach
Journal Title: Global Journal of Allergy - Year 2017, Vol 3, Issue 1
Abstract
Atopic dermatitis is one of the epidemically expanding non-infectious diseases in the 21 century. It poses immense challenges to both patients and physicians. With a steady growth in its incidence and prevalence, the disease carries a heavy social and economical burden. Herein we discuss the therapeutic algorithm for atopic dermatitis in accordance with the disease severity. We emphasize on the personalized approach in selecting the proper treatment method and regimen for each patient.
Authors and Affiliations
Zheleva Denitza, Darlenski Razvigor
Keywords
Related Articles
- EP ID EP342757
- DOI 10.17352/2455-8141.000016
- Views 83
- Downloads 0
Plastic Bronchitis: A Case Report
Plastic bronchitis is a rare disease characterized by the formation of bronchial casts that can cause partial or complete obstruction of the airway. In this case report, a patient aged four years, previously healthy, beg...
A Commentary: Is Context an Important Consideration in Asthma?
Asthma is a well known and high impact global health problem [1]. It shares, along with other prevalent entities, a number of not insignificant difficulties in the delivery of health care needs for it’s control [2]. From...
Nocturnal Asthma: A Special Type of Asthma
Nocturnal asthma is defined by a drop in forced expiratory volume in 1 second (FEV1) of at least 15% between bedtime and awakening in patients with clinical and physiologic evidence of asthma. Nocturnal asthma is associa...
Atopic Eczema - From Epidemiology to Therapeutic Approach
Atopic dermatitis is one of the epidemically expanding non-infectious diseases in the 21 century. It poses immense challenges to both patients and physicians. With a steady growth in its incidence and prevalence, the dis...
Iodixanol Nasal Solution Reduces Allergic Rhinoconjunctivitis Signs and Symptoms in Allergen BioCube®: Randomized Clinical Trial
Purpose: Allergic rhinitis (AR) affects ~20% of the population worldwide. The objectives of this study were to evaluate the safety and efficacy of iodixanol nasal solution (Nasapaque) for AR treatment, using the Allergen...